Facility
Sanofi Frankfurt Biotechnology Plant
Primary Sanofi insulin API manufacturing. E. coli fermentation for Lantus (glargine) and Toujeo production. WHO-prequalified facility for insulin glargine.
1
Inputs produced
1
Goods downstream
0
Incidents on record
0
Stories
What's produced here
1 input from this facility
Tap an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.